Court Opinion

ID: 5672547
Source: CourtListenerOpinion
Date Created: 2022-01-12 14:16:54.396921+00
Date Added: 2024-06-11T08:39:39.567611
License: Public Domain

*322Judgment, Supreme Court, New York County (Ira Gammerman, J.), entered February 8, 2002, which, insofar as appealed from as limited by the briefs, dismissed plaintiff’s informed consent cause of action pursuant to a trial ruling that dismissed such cause of action before the case was submitted to the jury, affirmed, without costs.
On or about August 1, 1995, a small nodule beneath plaintiffs right breast was diagnosed as angiosarcoma, a rare skin cancer believed to have resulted from radiation treatments previously administered for plaintiffs breast cancer. On August 9, 1995, plaintiffs surgeon, defendant Michael E Osborne, M.D., treated the angiosarcoma by removing a portion of plaintiffs breast (a quadrantectomy) rather than removing the entire breast (a mastectomy). Unfortunately, angiosarcoma reappeared in plaintiff’s right breast, and in June 1996, a mastectomy was performed. It is undisputed that plaintiff was free of angiosarcoma from the time of the 1996 mastectomy through the time of the trial, in October 2001.
In this action, plaintiff asserted two theories of liability against Dr. Osborne based on that physician’s August 1995 treatment of her angiosarcoma by quadrantectomy, rather than mastectomy. The first theory of liability was submitted to the jury as the question, “[W]as Dr. Osborne negligent in not performing a mastectomy in August 1995?” The jury’s unanimous answer to this question was “No.” Plaintiffs other theory of liability based on the events of August 1995 was that Dr. Osborne had failed to obtain her informed consent before performing the quadrantectomy. It was plaintiff’s contention that Dr. Osborne failed to inform her that the preferred treatment for her angiosarcoma was a mastectomy, a treatment that would have left her with a smaller risk of recurrence of the disease than did the quadrantectomy. The trial court’s refusal to submit this “informed consent” claim to the jury is the sole ground on which plaintiff seeks reversal of the judgment dismissing her complaint.
In seeking to have this case remanded for a trial of her informed consent claim, plaintiff overlooks the fact that the jury, in exonerating Dr. Osborne of malpractice, necessarily rejected plaintiffs claim that Dr. Osborne failed to obtain her informed consent to the quadrantectomy. Defendants’ expert witness, surgical oncologist Dr. Daniel F. Roses, testified that, although he understood a mastectomy to be the “generally recommended” treatment for breast-related angiosarcoma, a *323quadrantectomy would be a reasonable alternative if that is what the patient desired “after appropriate consultation and a recognition of the potential for recurrence” (emphasis added). Thus, the defense position at trial was that a quadrantectomy was within applicable standards of medical practice if, and only if, the patient chose that treatment after being fully informed that a quadrantectomy carried with it a greater risk of recurrence of the disease than would a mastectomy.1 The record is devoid of expert evidence that would support the defense verdict on the issue of malpractice if the jury had found that plaintiff was not fully informed of the relevant risks and alternatives when she consented to the quadrantectomy. Therefore, in determining that Dr. Osborne had not been negligent in performing the quadrantectomy, the jury necessarily found that, contrary to her trial testimony, plaintiff in fact had been fully informed when she consented to that operation. Accordingly, a jury has already determined in Dr. Osborne’s favor the very same issue raised by plaintiffs informed consent claim, namely, whether plaintiff gave informed consent to the quadrantectomy. Under these circumstances, to the extent the trial court may have erred in summarily dismissing the separate (and, in this case, redundant) informed consent claim, such error was entirely harmless.
It bears emphasis that the record fully supports the jury’s determination that plaintiff gave her informed consent to the quadrantectomy. To begin, plaintiff—who, as a psychiatrist, is herself a medical school graduate and physician—admits that she discussed with Dr. Osborne and at least one other physician (Dr. Peter Pressman) the option of treating her angiosarcoma by mastectomy. Further, the jury heard evidence flatly contradicting plaintiff’s uncorroborated testimony claiming that, before the quadrantectomy was performed, no one had explained to her that a mastectomy was the medically preferred treatment for her disease.
For example, on August 8, 1995, plaintiff met with oncologist Dr. Karen Animan to receive a second opinion. Dr. Antman’s written report of the consultation, which she dictated three days after the meeting occurred, states: “She [plaintiff] does not want the standard simple mastectomy for this disease.” In deposition testimony that was read into the record at trial, Dr. Ant-man elaborated on what she discussed with plaintiff:
*324“I brought up a mastectomy once or twice until it was obvious she was not going to do it. Then we started talking about alternatives. It probably took no more than three or four minutes to discuss what we could do if a mastectomy was not possible. . . .
“She said she was not having a mastectomy. I told her it was the standard of care. It was quite clear that she wasn’t going to have a mastectomy.
“So, then we tried to figure out what kind of operation we could do where we could get a decent margin around the tumor. . . ."
In the face of Dr. Antman’s disinterested testimony, plaintiff simply denied that Dr. Antman had ever discussed the possibility of a mastectomy with her.
Plaintiff also claimed that surgeon Dr. Michael Moore, another consulting physician she saw before the quadrantectomy was performed, failed to discuss the option of a mastectomy with her. When plaintiff was confronted with the statement in Dr. Moore’s report that he had “[d]iscussed complete removal” with plaintiff, she attempted to reconcile her position with the report by testifying that what Dr. Moore had discussed with her was a “complete skinning” of the chest, not removal of the breast itself. There was no expert testimony at trial to the effect that such a “skinning” operation was a recognized treatment option for plaintiffs disease.
Dr. Osborne, like Dr. Antman, testified that plaintiff was firmly opposed to undergoing a mastectomy. Dr. Osborne testified that, although he had advised plaintiff that a mastectomy was one of the treatment options for her angiosarcoma, plaintiff “refused to consider the option of mastectomy.” Dr. Osborne also testified that, on August 4, 1995, he advised plaintiff that the consensus of the medical conference that reviewed her case prior to the surgery was that “a quadrantectomy was reasonable and an acceptable route to go in the light of the fact that she was not wanting to go the route of mastectomy ” (emphasis added).
Dr. Peter Pressman was another physician whom plaintiff consulted between the angiosarcoma diagnosis and the surgery. In a letter to Dr. Osborne, dated August 8, 1995, Dr. Pressman wrote that, although he did not feel that the planned quadrantectomy was contraindicated, he still believed that “a total mastectomy should be carried out.” Dr. Pressman concluded his letter with the observation that “this [the desirability of a mastectomy] will need to be re-discussed, with the patient as she acquires more information from additional consultants” *325(emphasis added). Again, plaintiff claimed at trial that the contemporaneous medical record was inaccurate to the extent it indicated that the medical preference for a mastectomy had been discussed with her prior to her surgery.2
Plaintiff’s uncorroborated and self-serving testimony may have been sufficient—albeit barely sufficient—to create a triable issue as to what she was told prior to her surgery. The critical point missed by plaintiff, however, is that a jury has already been presented with that issue and has resolved it, based on the clear preponderance of the evidence, in Dr. Osborne’s favor. Again, the testimony of defendants’ medical expert was, in substance, that a quadrantectomy was within applicable standards of practice as a treatment for plaintiffs disease only if the patient chose a quadrantectomy after being informed of all relevant risks and alternatives. The jury, after hearing all the evidence, found that Dr. Osborne did not commit malpractice in performing a quadrantectomy rather than a mastectomy, meaning that the jury must have concluded that plaintiff chose to undergo the quadrantectomy after (in the words of defendants’ expert witness) “appropriate consultation and a recognition of the potential for recurrence.” There is no reason to require a new jury to resolve a question that a prior jury has already answered. Accordingly, the judgment is affirmed. Concur—Saxe, J.P., Sullivan, Williams and Friedman, JJ.

. By contrast, plaintiffs expert witness, pathologist Dr. John J. Shane, took the position that a mastectomy was the only acceptable treatment for angiosarcoma in the breast area, even if a fully informed patient preferred a quadrantectomy. The jury obviously rejected Dr. Shane’s testimony on this point.

. In regard to plaintiff’s position on the advice she received on the mode of treatment to be pursued, it seems pertinent to recognize an inherent anomaly. If, as plaintiff testified, she was already determined (based solely on Dr. Osborne’s recommendation) to have a quadrantectomy at the time she consulted with Drs. Antman, Moore and Pressman, the question arises why she was seeking a second opinion.